MICA and sarcoma: A narrow-spectrum HDACi entinostat has been shown to increase both NKG2D expression on NK cells and MICA/B in multiple tumor target cells, including sarcomas, augmenting NK cell cytotoxicity in vitro and in vivo and consequently suppressing sarcoma lung metastases in mice [195].